ArticleBiochemia medica2025
Cumulative IgG reagent carryover detected in carryover evaluation of urinary total protein testing using AU5800 biochemistry analyzer.
Article in Biochemia medica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Accurate measurement of urinary total protein (UTP) is crucial for diagnosing renal and systemic diseases. This study aims to comprehensively evaluate potential carryover scenarios in UTP testing using AU5800 biochemistry analyzer and to identify factors influencing assay accuracy. Materials and methods: High-concentration quality control materials and pure water was used to evaluate specific sample probe carryover. Additionally, 24-hour mixed urine samples from patients were used to evaluate specific carryover from the reagent probe, mixbars, and cuvettes. For cumulative sample carryover evaluation, pure water was used as reagent and mixed serum as sample for continuous testing. During the process, 24-hour urine samples were interspersed, and UTP concentrations were measured at 0, 10, 20, and 30 minutes. Cumulative reagent carryover was evaluated by testing pure water sequentially with eight reagents sharing the same analytical unit and inner cuvettes as UTP, with UTP concentrations of 24-hour urine samples recorded at 0, 10, 20, and 30 minutes. Results: Specific carryover from the sample probe, reagent probe, mixbars, and cuvettes was not detected during carryover evaluation of UTP testing. However, a significant cumulative reagent carryover of Immunoglobulin G (IgG) reagent was observed, while no cumulative sample carryover was identified. Conclusions: The full range of possible carryover scenarios in UTP testing was evaluated using AU5800 biochemistry analyzer. Our data provide valuable references for evaluating carryover in laboratories, ensuring the accuracy and reliability of laboratory results.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.